Promising skin cancer combo study halted early
NCT ID NCT03901573
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tested whether adding an experimental drug (NT-I7) to an existing immunotherapy (atezolizumab) could help people with advanced skin cancers like melanoma, Merkel cell carcinoma, and squamous cell carcinoma. The trial enrolled 31 adults whose cancers had not responded to or had stopped responding to standard treatments. The study was stopped early, but the results may still provide useful information for future cancer therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44106, United States
-
Dana Farber
Boston, Massachusetts, 02215, United States
-
MGH
Boston, Massachusetts, 02215, United States
-
Mt Sinai
New York, New York, 10029, United States
-
Northwestern University
Chicago, Illinois, 60208, United States
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.